Thanks DD. While it's nice to see Medivir expand beyond TMC435, I'm not sure what to make of this project. I was looking at their older annual reports on their Web site and as far back as 2001 they had cathepsin K PIs against osteoporosis on their way towards the lead optimization phase. This has been a really slow going project. Guess we'll get the first hint if it will bear fruit in 1Q13.